CompoAtlas

PREGNA-DHA

Natural health product licensed in Canada

Licence holder
Pharmaline Inc.
NPN or DIN-HM
80071084
Status
Inactive licence
Licence date
13 July 2016
Revision date
Not provided
Form
Capsule, remplie de liquide
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine C

Source : Acide ascorbique

50 milligrammeNot calculated
Zinc

Source : Oxyde de zinc

24 milligrammeNot calculated
Vitamine E

Source : Acétate de dl-alpha tocophéryle

10 milligrammeNot calculated
Choline40 milligrammeNot calculated
Iode

Source : Iodure de potassium

100 microgrammesNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

4.6 milligrammeNot calculated
Riboflavine4.6 milligrammeNot calculated
Niacinamide

Source : Niacinamide

4.6 milligrammeNot calculated
Huile de poisson

Source : Engraulidae - en entier

500 milligrammeNot calculated
Fer

Source : Fumarate de fer (II)

15 milligrammeNot calculated
Thiamine

Source : Chlorhydrate de thiamine

4.6 milligrammeNot calculated
Bêta-carotène

Source : bêta-carotène

1 milligrammeNot calculated
Folate500 microgrammesNot calculated
Calcium

Source : Phosphate de calcium, dibasique

250 milligrammeNot calculated
Vitamine D

Source : Cholécalciférol

2.5 microgrammesNot calculated
Vitamine B12

Source : Cyanocobalamine

30 microgrammesNot calculated
Magnésium

Source : Oxyde de magnésium

65 milligrammeNot calculated
Cuivre0.1 milligrammeNot calculated

Non-medicinal ingredients

Glycérine, Huile de fève de soja, Gélatine

PopulationAgeQuantity per servingFrequency
Sub Pop to be createdNot specified1 Capsuleminimum: 1 day ; maximum: 2 days

Uses authorised in Canada

Helps to reduce the risk of neural tube defects when taken daily atleast three months prior to pregnancy and during early pregnancy. Helps maintain/support cardiovascular health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80071084

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line